
Ferran Nadeu
Grup de recerca
- Patologia molecular en neoplàsies limfoides Post-doctoral researcher (R2A)
Publicacions destacades
-
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Autors: Knisbacher BA, Lin Z, Hahn CK, Nadeu F, Duran-Ferrer M, Stevenson KE, Tausch E, Delgado J, Barbera-Mourelle A, Taylor-Weiner A, Bousquets-Muñoz P, Diaz-Navarro A, Dunford A, Anand S, Kretzmer H, Gutierrez-Abril J, López-Tamargo S, Fernandes SM, Sun C, Sivina M, Rassenti LZ, Schneider C, Li S, Parida L, Meissner A, Aguet F, Burger JA, Wiestner A, Kipps TJ, Brown JR, Hallek M, Stewart C, Neuberg DS, Martín-Subero JI, Puente XS, Stilgenbauer S, Wu CJ, Campo E, Getz G .Referència: Nature Genetics 2022. -
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Autors: Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M, Dawson KJ, Kulis M, Diaz-Navarro A, Villamor N, Melero JL, Chapaprieta V, Dueso-Barroso A, Delgado J, Moia R, Ruiz-Gil S, Marchese D, Giró A, Verdaguer-Dot N, Romo M, Clot G, Rozman M, Frigola G, Rivas-Delgado A, Baumann T, Alcoceba M, González M, Climent F, Abrisqueta P, Castellví J, Bosch F, Aymerich M, Enjuanes A, Ruiz-Gaspà S, López-Guillermo A, Jares P, Beà S, Capella-Gutierrez S, Gelpí JL, López-Bigas N, Torrents D, Campbell PJ, Gut I, Rossi D, Gaidano G, Puente XS, Garcia-Roves PM, Colomer D, Heyn H, Maura F, Martín-Subero JI, Campo E .Referència: Nature Medicine 2022. -
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Autors: Nadeu F, Royo R, Clot G, Duran-Ferrer M, Navarro A, Martín S, Lu J, Zenz T, Baumann T, Jares P, Puente XS, Martín-Subero JI, Delgado J, Campo E .Referència: Blood 2021. -
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Autors: Nadeu F, Martin-Garcia D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggros M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera-Cortada I, Siebert R, Colomer D, Torrents D, Gine E, López-Guillermo A, Küppers R, Martin-Subero JI, Puente XS, Beà S, Campo E .Referència: Blood 2020. -
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
Autors: Nadeu, F; Mas-de-les-Valls, R; Navarro, A; Royo, R; Martin, S; Villamor, N; Suarez-Cisneros, H; Mares, R; Lu, JY; Enjuanes, A; Rivas-Delgado, A; Aymerich, M; Baumann, T; Colomer, D; Delgado, J; Morin, RD; Zenz, T; Puente, XS; Campbell, PJ; Bea, S; Maura, F; Campo, E.Referència: Nature Communications 2020. -
Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia
Autors: Nadeu F; Diaz-Navarro A; Delgado J; Puente X; Campo E.Referència: Annual Review Of Pathology-Mechanisms Of Disease 2020. -
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Autors: Nadeu, F; Clot, G; Delgado, J; Martin-Garcia, D; Baumann, T; Salaverria, I; Bea, S; Pinyol, M; Jares, P; Navarro, A; Suarez-Cisneros, H; Aymerich, M; Rozman, M; Villamor, N; Colomer, D; Gonzalez, M; Alcoceba, M; Terol, MJ; Navarro, B; Colado, E; Payer, AR; Puente, XS; Lopez-Otin, C; Lopez-Guillermo, A; Enjuanes, A; Campo, E.Referència: Leukemia 2018. -
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Autors: Nadeu, F; Delgado, J; Royo, C; Baumann, T; Stankovic, T; Pinyol, M; Jares, P; Navarro, A; Martin-Garcia, D; Bea, S; Salaverria, I; Oldreive, C; Aymerich, M; Suarez-Cisneros, H; Rozman, M; Villamor, N; Colomer, D; Lopez-Guillermo, A; Gonzalez, M; Alcoceba, M; Terol, MJ; Colado, E; Puente, XS; Lopez-Otin, C; Enjuanes, A; Campo, E.Referència: Blood 2016.
Projectes destacats
-
Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints
Investigador/a principal: Ferran Nadeu PratCodi: EHA Junior Research Grant 2021 (RG-202012-00245)Durada: 01/01/2022 - 31/12/2024 -
Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints
Investigador/a principal: Ferran Nadeu PratCodi: International Award for Research in Leukaemia 2021-2022 (LADY_TATA_21_3223)Durada: 01/10/2021 - 30/09/2022 -
Tracking the progression and transformation of chronic lymphocytic leukemia
Investigador/a principal: Ferran Nadeu PratCodi: American Association for Cancer Research (AACR)-Amgen Fellowship in Clinical/Translational Cancer Research (21-40-11-NADE)Durada: 01/07/2021 - 30/06/2023